European study shows that prevention in patients with inherited cancer risks produces substantial cost benefits

Screening people with the rare, inherited cancer-causing condition Li-Fraumeni syndrome (LFS) brings both medical and economic benefits to patients and health care systems, according to research to be presented to the annual conference of the European Society of Human Genetics. ...